Hemanext
PrivateLast Round
Grant
Oct 14, 2025
Est. Valuation
$172M
Total Funding Raised
$100.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hemanext is a medical technology company that develops oxygen-controlled processing and storage systems to preserve the quality and function of red blood cells for transfusion.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemanext Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Hemanext Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 14, 2025 | ||||
| Series B Extension | Jul 22, 2025 | ||||
| Series B Extension | Jan 27, 2025 | ||||
| Series B Extension | Oct 1, 2024 | ||||
| Strategic | Jun 7, 2023 | ||||
Series B | Nov 7, 2022 |
Key People
Founding team and executive leadership
Hemanext Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| Antaeus Enterprises, Inc. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2025
$3M grant from the National Heart, Lung, and Blood Institute.
- Jun 12, 2025
Data presented at the European Hematology Association 2025 Congress.
Hemanext Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hemanext's valuation, stock price, and market status.